SI-BONE to Present at Notable Growth Conference
SI-BONE, Inc. (Nasdaq: SIBN), a prominent medical device company, is gearing up to showcase its advancements in treating sacropelvic disorders at the upcoming Canaccord Genuity Annual Growth Conference. This event promises to be an insightful gathering, where experts will come together to discuss evolving medical technologies.
Conference Participation Details
During this highly anticipated conference, SI-BONE’s management will host an engaging fireside chat on Tuesday, attracting both industry professionals and investors. While the exact venue is still under wraps, the discussions will commence at noon Pacific Time, making it accessible for a wide audience across various time zones.
How to Access the Event
Investors and interested parties are encouraged to tune in by registering for the live audio webcast. Those wishing to learn about the innovative solutions presented by SI-BONE can visit the webcast platform. The event will also be archived for future viewing, ensuring that anyone missing the live session can catch up later.
About SI-BONE, Inc.
SI-BONE is known globally for its pioneering work in developing technologies tailored for surgical interventions addressing sacropelvic disorders. Since its inception, the company's iFuse Implant System has transformed the landscape of minimally invasive surgery, emerging as a standard option for clinicians in the field. With over 125,000 procedures supported by a growing network of more than 4,600 physicians, SI-BONE remains at the forefront of innovation.
Scientific Backing and Clinical Evidence
The company’s technologies are backed by a robust body of clinical evidence, which includes over 175 peer-reviewed publications spotlighting their effectiveness. Through a commitment to research and quality, SI-BONE has not only solidified its market position but also expanded into adjacent areas such as adult deformity and pelvic trauma.
Future Innovations in Surgical Solutions
As SI-BONE looks ahead, the company continues to explore novel solutions beyond SI joint fusion, aiming to improve outcomes in various surgical fields. This forward-thinking approach not only enhances their product line but also addresses the evolving needs of healthcare practitioners and their patients.
Connecting with SI-BONE
For those seeking more insights about SI-BONE and its product offerings, the official website serves as a comprehensive resource. Interested parties can explore detailed information regarding their technology, its benefits, and potential risks involved.
Investor Relations
The Investor Relations team at SI-BONE is dedicated to maintaining open lines of communication with stakeholders. For inquiries or further information, investors are encouraged to reach out via official contact channels. This open dialogue supports transparency and fosters a deeper understanding of the company's objectives and performance.
Frequently Asked Questions
What is SI-BONE, Inc. known for?
SI-BONE is recognized for its innovative technologies in addressing sacropelvic disorders through minimally invasive surgical solutions.
When will SI-BONE be presenting at the conference?
The company will be hosting their fireside chat during the Canaccord Genuity Annual Growth Conference on a Tuesday, with specific details provided prior to the event.
How can investors participate in the conference?
Investors can participate by registering for the live audio webcast available through the conference platform.
Where can I find more about SI-BONE's products?
For more information about SI-BONE's products and technologies, visit their official website.
Who can I contact for investor inquiries?
For investor inquiries, reach out to Saqib Iqbal at SI-BONE.
